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The ethics of sham surgery in research
James W. Jones, MD, PhD,a Laurence B. McCullough, PhD,b and Bruce W. Richman, MA,a Columbia,
Mo; and Houston, Tex
As the only surgeon appointed to the Institutional
Review Board of a large private teaching hospital, you
are asked to review a research protocol submitted by an
orthopedic colleague. The study proposes to compare a
patient group receiving a well-established arthroscopic
procedure to a control group with the same pathology
randomized to receive a sham surgical procedure. You
determine that the question to be answered is impor-
tant, the scientific design is solid, the informed consent
appropriate, and risks to patients in both groups are
minimized. Patients in the control group will be se-
dated rather than anesthetized in the OR. Your recom-
mendation to the committee is:
A. Sham surgery has no role in the ethical conduct of
surgical research, and the proposal should not be ap-
proved.
B. Sham surgery is an ethical research instrument if the
likely benefit to future patients exceeds carefully limited
risks to the control group.
C. Sham surgery is essential to the evaluation of surgical
therapy, and the proposal should be approved.
D. Your institution should not be among the first to ex-
plore this controversy.
E. All randomized studies are unethical because they do
not individualize care based upon patient evaluation.
The best response is B. Choice A is the least acceptable.
“Sham” derives from a Middle English variant of
“shame”, and, as the word suggests, sham surgery has
always been ethically controversial. Most everyone’s first
impression is that it is not ethically defensible to subject a
patient to the risks of anesthesia and a painful invasive
surgical procedure with no apparent counterbalancing clin-
ical benefits.1 Research involving sham or placebo surgery
would therefore appear to violate the ethical principle of
non-maleficence, the obligation not to harm patients.2
On closer examination, however, this objection to
sham surgery as a legitimate tool in clinical research rests on
an assumption that current surgical techniques have been
reliably shown to be clinically beneficial. In fact, surgical
procedures are most often developed and accepted as the
standard of care without benefit of the rigorous controlled
clinical trials required for the introduction of new medica-
tions. The ethics of innovation in surgery without confor-
mity to the discipline of scientific method has received
recent critical attention in the literature.3,4 Some writers
have based their ethical objections to research using sham
surgery controls on assumptions that the controls will be at
greater risk than the designated treatment group, that they
will be left with both their ailments and the pain of surgery,
and that they will receive no benefit from study participa-
tion. By utilizing a sham surgery controlled study model,
investigators in a recent study were able to conclude that a
widely-used orthopedic operation was ineffective, thereby
eliminating the surgical risk and expense to which 50,000
patients a year had been needlessly subjecting themselves.5
The “placebo effect” is widely acknowledged in medi-
cine but generally disregarded in surgery. The placebo is
usually thought of as an inactive compound administered
to a naı¨ve patient as if it were medication. The deception
underlying a placebo effect is generally considered unethi-
cal in the clinical practice of surgery. Nonsurgical specialties
diligently compare new medications to placebos in similar
groups of subjects to factor out the placebo response.
Surgeons, too, must properly recognize and study these
powerful psychophysiologic effects. Well-designed sham-
controlled clinical trials of innovative surgical interventions
could improve the quality of surgical science in the same
way that pharmaceutical placebos improve the evaluation of
new medications.
Because research using sham surgery is not inherently
more harmful or less beneficial than unproven active sur-
gery, it cannot be considered intrinsically unethical, and
choice A can therefore be firmly set aside. There is an
essential ethical requirement that the sham surgery must
pose less risk to subjects than the procedure being tested,
which eliminates from participation in sham-controlled
surgical studies the critically ill, the acutely traumatized,
and patients whose conditions can be successfully resolved
with a proven safe and effective procedure. Our profession’s
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defining ethical principles require that no surgeon perform
a procedure of no possible benefit to patients.
When conditions for limiting risk are met, when the
effectiveness of the active procedure is uncertain, and pro-
jections of future benefit seem realistic, sham surgery can be
an ethically and scientifically acceptable research instru-
ment.1 Present risks to study subjects must be balanced by
potential benefits to future recipients from the knowledge
to be gained. Participation in the sham surgery study group
must not prevent the patient from subsequently receiving
an effective surgical procedure. With assessed risk to sham
surgery subjects lower than that of patients in the study’s
active surgery arm, control group patients benefit when
outcome measures find the active procedure ineffective.
Observing these conditions, choice B is the best recom-
mendation.
Choice C errs in its absolutism. Sham surgery can be,
but is not always, critical to a well-designed and well-
conducted surgical clinical trial. Horng and Miller restrict
its justifiable use to trials in which the outcomes to be
measured involve an irreducible subjective element which
no alternative study design can adequately address.1 Fur-
thermore, the research question to be answered in a study
utilizing a sham surgery component should be of sufficient
importance to benefit future patients beyond the level of
risk to which the current subjects are exposed. The sham-
controlled study is but one of many effective research
models available to surgical scientists. As with other meth-
ods, it should be selected only when it is the instrument
best-suited to test a particular scientific hypothesis.
Choice D avoids well-reasoned ethical analysis and
ensures that the scientific work will not be accomplished,
failing the medical profession on both counts. Clinical
research in every medical specialty is by its nature intellec-
tually challenging, and is unlikely to be well-conducted by
those without an aptitude for confronting imperfections in
the status quo.
Choice E confuses clinical research and clinical care.
The purpose of clinical research is to develop improved
treatment methods for future patients. A properly admin-
istered informed consent process makes clear to prospective
study subjects that they may derive no clinical benefit from
study participation, and that study procedures are uni-
formly determined by the protocol and not by the individ-
ual patient characteristics which guide clinical care. Like-
wise, sham surgery in clinical research should not be
confused with sham surgery in clinical care, where it has no
legitimate or ethically supportable role, even when no
effective therapeutic modality is available. We know how to
design and conduct clinical trials that are ethically consis-
tent with the additional patient risks inherent to them. As
an argument against controlled surgical research, choice E
therefore misses the mark.
You and the other IRB members have a heightened
responsibility to ensure that sham-controlled surgical stud-
ies are methodologically sound, address important ques-
tions, and are scrupulous about limiting patient risk. Prop-
erly designed and carefully conducted placebo surgery
should present no greater or lesser ethical dilemma than
other methods of scientific control.
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